AWH - Aspira Women's Health Annual Revenue Growth (Last Twelve Months)

Aspira Women's Health (AWH) possesses significant pricing power due to its unique early cancer detection methods. The trailing twelve-month (TTM) sales growth rate reflects this trend, where the 16.40 mark serves as the current indicator. Nicole Sandford's team focuses on test accuracy, while high clinic loyalty and FDA support ensure business resilience within the women's health sector.
Aspira Women's Health, Inc. - analytical breakdowns and key metrics (AWH)

Long-term risk control requires an analysis of actual business dynamics to avoid purchasing a degrading asset during a temporary price dip. The year-over-year revenue growth trend over a rolling year measures daily sales changes over 12 months, confirming that physician confidence in Ova1 AI tests is converting into stable cash flow and sustainable market share expansion for Aspira Women's Health (AWH).